RWJ Health Connect | Patient PortalGo
  • 1-888-MD-RWJUH
  • YouTube

Health Library

Results 1 - 10 of 68
Search Results:  Z (68)
  • Zydelig Approved for Three Types of Blood Cancer

    Posted: 07/30/2014

    Zydelig Approved for Three Types of Blood Cancer WEDNESDAY, July 23, 2014 (HealthDay News) -- Zydelig (idelalisib) has been approved by the U.S. Food and Drug Administration to treat relapsed forms of blood cancer, including chronic lymphocytic leukemia (CLL), follicular B-cell non-Hodgkin lymphoma (FL) and small lymphocytic lymphoma (SLL), the FDA said Wednesday in a news release. The approval for the three forms of blood cancer covers instances when the cancer returns despite treatment with at least o...

  • Zontivity Approved For People at High-Risk of Heart Attack, Stroke

    Posted: 05/14/2014

    Zontivity Approved For People at High-Risk of Heart Attack, Stroke THURSDAY, May 8, 2014 (HealthDay News) -- Zontivity (vorapaxar) tablets have been approved by the U.S. and Drug Administration for people at high risk of heart attack or stroke. The drug is the first in a new class called protease-activated receptor-1 antagonists, designed to weaken the tendency of platelets to clump and form a blood clot. But the agency said the drug increases users' risks of developing life-threatening bleeding. Zontiv...

  • Zest for Life Can Be a Moving Experience

    Posted: 01/27/2014

    Zest for Life Can Be a Moving Experience MONDAY, Jan. 20, 2014 (HealthDay News) -- Happier seniors can look forward to greater mobility as they age than their gloomier peers, new research suggests. The findings don't prove that happiness preserves mobility. However, "the research suggests that enjoyment of life contributes to healthier and more active old age," said study author Andrew Steptoe, director of the Institute of Epidemiology and Health Care at University College London. And it's not just beca...

  • Zinc Shows Promise Against Deadly Jellyfish Venom

    Posted: 12/15/2012

    Zinc Shows Promise Against Deadly Jellyfish Venom WEDNESDAY, Dec. 12 (HealthDay News) -- A zinc compound could prove a lifesaver for people who suffer potentially deadly stings from the Australian box jellyfish, according to researchers who tried the treatment in mice. The jellyfish are among the most venomous creatures in the world. Researchers have long tried to learn more about why the jellyfish's venom is so deadly and how to counter it. In this study, researchers developed ways to extract venom fro...

  • Zytiga's Use Expanded for Advanced Prostate Cancer

    Posted: 12/12/2012

    Zytiga's Use Expanded for Advanced Prostate Cancer MONDAY, Dec. 10 (HealthDay News) -- U.S. Food and Drug Administration approval of Zytiga (abiraterone acetate) has been expanded to include treating late-stage castration-resistant prostate cancer before the administration of chemotherapy, the agency said Monday. The drug, designed to decrease production of the male sex hormone testosterone, was first approved in November 2011. Testosterone is thought to spur the growth of prostate tumors, the FDA said ...

  • Zinc Harder to Absorb in Old Age, Animal Study Shows

    Posted: 11/16/2012

    Zinc Harder to Absorb in Old Age, Animal Study Shows THURSDAY, Oct. 11 (HealthDay News) -- A study in mice has helped researchers identify how zinc deficiencies might develop in older people -- even when they are consuming the recommended levels of this important mineral in their diet. Zinc deficiency in people can lead to a weakened immune system and increased inflammation associated with a wide range of health problems, including cancer, heart disease, autoimmune disease and diabetes. The researchers,...

  • Zaltrap Approved for Advanced Colorectal Cancer

    Posted: 11/16/2012

    Zaltrap Approved for Advanced Colorectal Cancer FRIDAY, Aug. 3 (HealthDay News) -- Zaltrap (ziv-afilbercept) has been approved by the U.S. Food and Drug Administration in combination with a FOLFIRI chemotherapy regimen for adults with advanced metastatic (spreading) colorectal cancer, the agency said Friday. FOLFIRI stands for a regimen that includes folinic acid, fluorouracil and irinotecan. Zaltrap, among a class of drugs called angiogenesis inhibitors, restricts tumor growth by inhibiting their blood...

  • Zinc Pills May Shorten Colds, Analysis Suggests

    Posted: 11/16/2012

    Zinc Pills May Shorten Colds, Analysis Suggests MONDAY, May 7 (HealthDay News) -- Those suffering from the common cold will try almost anything to relieve their symptoms, but a cure has yet to be found. A new Canadian analysis has revealed that zinc tablets may help patients suffer a little less, but side effects are common. "Although it is possible that oral zinc preparations impact symptoms of the common cold, there is currently insufficient evidence to recommend its use in children and only a weak ra...

  • Zioptan Eyedrops Approved for Glaucoma, Ocular Hypertension

    Posted: 11/15/2012

    Zioptan Eyedrops Approved for Glaucoma, Ocular Hypertension MONDAY, Feb. 13 (HealthDay News) -- Merck's Zioptan drops (tafluprost ophthalmic solution) has been approved by the U.S. Food and Drug Administration to lower pressure within the eye among people with high blood pressure of the eye (ocular hypertension) or open-angle glaucoma, the most common form of the disease. Approval was based on five clinical studies involving 905 people, the drug's maker said in a news release. The most common side effec...

  • Zelboraf

    Posted: 11/15/2012

    Zelboraf A drug used to treat advanced melanoma that has a mutated (changed) form of a cell protein called BRAF. It is also being studied in the treatment of other types of cancer. Zelboraf blocks this mutated protein, which may stop the growth of cancer cells. It is a type of kinase inhibitor and a type of targeted therapy agent. Also called BRAF (V600E) kinase inhibitor RO5185426, PLX4032, RG7204, and vemurafenib.